Muscular Weakness
14
0
0
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (14)
Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients
Effects of Measurement of Handgrip Strength on Physical Activity Level for Patients With Diabetes Type 2
Biomarker for Pompe Disease (BioPompe)
Biomarker for Duchenne Muscular Dystrophy
Muscular Respiratory Involvement and Systemic Sclerosis
Lateral Neck Flexor Endurance and Hyperlaxity
Pilates and Dance to Breast Cancer Patients Undergoing Treatment
Evaluation of a Textile Scapula Orthosis
Training Intrinsic Foot Muscles
Can Blood Flow Restriction Therapy Improve Strength for Shoulder External Rotators Better Than Exercise Alone
Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease
Supplement Study: Strength, Testosterone, Sexual Function, Quality of Life
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
Enhancing Gluteus Maximus Recruitment